Aclaris Therapeutics (ACRS) Liabilities from Discontinued Operations (2018 - 2023)

Aclaris Therapeutics' Liabilities from Discontinued Operations history runs 6 years deep, the most recent figure standing at 2202000.0 for Q4 2023.

• In Q4 2023, Liabilities from Discontinued Operations changed 0.0% year-over-year to 2202000.0; the TTM figure through Dec 2023 stood at 2202000.0 (changed 0.0% YoY), while the FY2023 annual figure was 2202000.0, changed 0.0% from the prior year.
• Liabilities from Discontinued Operations was 2202000.0 for Q4 2023 at Aclaris Therapeutics, roughly flat from 2202000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 14501000.0 in Q3 2019 to a low of 2198000.0 in Q3 2021.
• Historically, Liabilities from Discontinued Operations has averaged 3228666.67 across 5 years, with a median of 2202000.0 in 2021.
• The sharpest annual moves came in 2019 and 2020: Liabilities from Discontinued Operations surged 238.79% in 2019, then slumped 77.24% in 2020.
• A 5-year view of Liabilities from Discontinued Operations shows it stood at 4157000.0 in 2019, then retreated by 25.16% to 3111000.0 in 2020, then decreased by 29.22% to 2202000.0 in 2021, then changed by 0.0% to 2202000.0 in 2022, then changed by 0.0% to 2202000.0 in 2023.
• The last three Liabilities from Discontinued Operations figures came in at 2202000.0 (Q4 2023), 2202000.0 (Q3 2023), and 2202000.0 (Q2 2023), per Business Quant data.